by John Conrad | Aug 4, 2025 | Policy News
Illinois companies stand to lose $90 million in annual funding if federal programs expire September 30th Illinois life sciences companies and associations have until August 15th to sign onto a group letter urging the state’s Congressional Delegation to...
by John Conrad | Jun 4, 2024 | iBIO News
The biotech industry is facing a stark contrast between the robust state of scientific innovation and the challenging financial and economic environment, according to the latest EY Beyond Borders reportEY Beyond Borders report. While exciting advancements continue in...
by John Conrad | Oct 31, 2022 | iBIO in the News
Illinois’ bioscience industry has seen major growth in recent years as government grants and private investors have pumped money into the sector, according to a new report. But a shaky economy and venture-capital slowdown this year will likely hamstring...
by John Conrad | Sep 19, 2022 | iBIO in the News
Although Chicago is the third largest city in the United States, when it comes to its position as a leading biotech hub, the second city ranks far below many other U.S. locations. That is starting to change, however, as new companies move into this heart of...
by John Conrad | Aug 3, 2022 | iBIO in the News
llinois is recognized as a national leader in the life sciences industry, which employs more than 41,000 people across the state. A 2019 report found the overall economic output of the life sciences industry in Illinois was $98 billion, with pharmaceutical research...
